Kevin Sharer concluded his decade-long reign at the helm of the world’s largest biotechnology company on May 23, when he handed the CEO reins over to Robert Bradway. But the former chief executive of Thousand Oaks-based Amgen will continue to keep a leased office, secretary and other perks through the end of 2017, according to Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.